Patent details

EP1155696 Title: Use of olanzapine for the manufacture of a medicament for neuroprotection

Basic Information

Publication number:
EP1155696
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP012029864
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Use of olanzapine for the manufacture of a medicament for neuroprotection
French Title of Invention:
Utilisation de l'olanzapine pour la fabrication d'un médicament pour la neuroprotection
German Title of Invention:
Verwendung von Olanzapin zur Herstellung eines Arzneimittels zur Neuroprotektion
SPC Number:

Dates

Filing date:
09/04/1998
Grant date:
03/03/2004
EP Publication Date:
03/03/2004
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/11/2001
EP B1 Publication Date:
03/03/2004
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
09/04/2010
Expiration date:
09/04/2018
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/04/1998
 
 

Name:
ELI LILLY AND COMPANY
Address:
Lilly Corporate Center, Indianapolis, Indiana 46285, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
03/03/2004
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
Bymaster Franklin Porter
Address:
United States (US)

2

Name:
Tollefson Gary Dennis
Address:
United States (US)

Priority

Priority Number:
43094
Priority Date:
15/04/1997
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/551;
Filing date Document type Number of pages